Alzheimer's disease is the most common type of dementia, causing progressive cell loss in the brain and affecting memory, thinking skills, and daily life activities. While its exact cause is not fully known, age, genetic predisposition, and certain lifestyle factors are thought to influence disease risk.
Maintaining an adequate blood flow to the brain is important for preserving cognitive function. Research shows there may be a relationship between cardiovascular health and cognitive health, and that risk factors affecting vascular health (such as high blood pressure, diabetes, and high cholesterol) may also be linked to cognitive decline.
EECP (Enhanced External Counterpulsation) is an FDA-approved method, used mainly in the treatment of angina, that supports circulation through cuffs that work in sync with the heartbeat. EECP's possible effects on overall cerebral blood flow have been examined in a limited number of studies. In a recent randomized controlled trial, full-pressure EECP application in participants diagnosed with early-stage Alzheimer's disease was reported to be associated with statistically significant improvement in cognitive test scores and daily living activity measures compared with sham application. However, this is a single study; the findings need to be confirmed by independent research groups and in larger patient populations. As it stands, this single study does not establish that EECP treats, improves, or halts the progression of Alzheimer's disease.
EECP is not an approved or standard treatment method for Alzheimer's disease. People diagnosed with Alzheimer's disease, or who have symptoms suggestive of it, should be evaluated by a neurologist.
Protecting your cardiovascular health, as part of your overall circulatory system, may indirectly support your cognitive health as well. However, if you have concerns about Alzheimer's disease, it is important to consult a neurologist for proper evaluation and treatment.
Sources: Juni JE, Burns JM, Salat DH, Hill D, Tally S, Martin JS, Devous MD, Moriarty PM. "Treatment of Clinically Diagnosed Alzheimer's Disease by External Counterpulsation: A Randomized Clinical Trial." American Journal of Alzheimer's Disease & Other Dementias, 2026. DOI: 10.1177/15333175261451918. — General resources from the Alzheimer's Association.
Note: This content is for general informational purposes only and is not a substitute for medical advice; it does not imply that EECP is an approved, standard treatment for Alzheimer's disease, nor can it be said to halt its progression or improve the disease.
Contact us now for a free initial assessment, or fill out our short test.